Supplementary Materials

The PDF file includes:

  • Figure S1 (related to Figure 1): Intracellular antibody expression in circulating plasmablasts.
  • Figure S2 (related to Figure 1): Circulating follicular helper T cells in blood of SARS-CoV-2 patients.
  • Figure S3 (related to Figure 2): Reproducibility of photonic ring immunoassay to detect anti-RBD and anti-NC antibodies
  • Figure S4 (related to Figure 2): Early detection of anti-RBD antibodies in serum from SARS-CoV-2 patients.
  • Figure S5 (related to Figure 3): Neutralizing activity of serum, BAL and saliva from SARS-CoV-2 patients.
  • Table S1: Demographics, baseline characteristics, treatment, and outcome of 38 patients with COVID-19 assessed for blood plasmablasts.
  • Table S2: Demographics and baseline characteristics of patients with COVID-19.
  • Table S3: Clinical characteristics, laboratory results, treatment, and outcome of patients with COVID-19.
  • Table S4: Virus-specific IgG, IgM, and IgA titers according to the clinical course of the disease in patients with COVID-19
  • Table S5: Demographics, baseline characteristics, treatment, and outcome of patients with acute respiratory distress syndrome during course of COVID-19.
  • Table S6: Human antibodies used for B and T cell phenotyping.

[Download PDF]

Other Supplementary Material for this manuscript includes the following: